LQDA
Liquidia CorpCompany Information
- Company Name
- Liquidia Corp
- CIK
- CIK0001819576
- Category
- Non-accelerated filer
- Ticker: Exchange
- LQDA: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- LQDA
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-19
- Last sale
- 2026-09-14
- Shares purchased (TTM)
- 5,300
- Shares sold (TTM)
- 2,885,257
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 70,842,044
- Shares outstanding
- 88,887,744
- Ownership
- 79.70%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- -12.86%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 284 | 223 | 191 | 157 | 173 | 170 | 176 | 204 | 133 | 158 | 84 | 76 | ||||||
| Accounts Receivable Net Current | 109 | 74 | 54 | 36 | 10 | 1 | 3 | 4 | 3 | 3 | 4 | 3 | ||||||
| Inventory Gross | - | - | - | - | - | - | - | - | 7 | 4 | - | - | ||||||
| Inventory Net | 36 | 29 | 24 | 25 | 6 | 1 | 0 | 0 | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 9 | 8 | 5 | 9 | 6 | 5 | 6 | 6 | 4 | 4 | 2 | 3 | ||||||
| Assets Current | 438 | 333 | 273 | 227 | 196 | 177 | 185 | 214 | 147 | 168 | 90 | 83 | ||||||
| Property Plant And Equipment Net | 35 | 21 | 12 | 11 | 10 | 8 | 8 | 8 | 6 | 6 | 4 | 4 | ||||||
| Operating Lease Right Of Use Asset | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 1 | 1 | 2 | 2 | 2 | ||||||
| Intangible Assets Net Excluding Goodwill | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Goodwill | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Deferred Income Tax Assets Net | 1 | 1 | - | - | - | - | - | - | - | - | - | - | ||||||
| Restricted Cash Noncurrent | 4 | 4 | 4 | 4 | 4 | - | - | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 19 | 17 | 13 | 9 | 22 | 16 | 11 | 8 | 0 | 0 | 0 | 0 | ||||||
| Assets | 522 | 402 | 328 | 276 | 257 | 227 | 230 | 253 | 177 | 197 | 118 | 112 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 13 | 11 | 4 | 6 | 11 | 9 | 5 | 2 | 6 | 2 | 1 | 2 | ||||||
| Operating Lease Liability Current | - | - | - | - | - | - | - | - | - | - | 1 | 1 | ||||||
| Finance Lease Liability Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Liabilities Current | 189 | 150 | 136 | 103 | 78 | 61 | 42 | 34 | 24 | 22 | 19 | 12 | ||||||
| Litigation Reserve Noncurrent | 9 | 9 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 2 | 3 | ||||||
| Deferred Income Tax Liabilities Net | 1 | 1 | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 327 | 293 | 283 | 254 | 242 | 178 | 151 | 142 | 115 | 100 | 71 | 64 | ||||||
| Finance Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | - | 0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 | - | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 694 | 682 | 671 | 663 | 652 | 645 | 637 | 632 | 561 | 556 | 476 | 450 | ||||||
| Retained Earnings Accumulated Deficit | -499 | -573 | -626 | -641 | -637 | -596 | -557 | -521 | -498 | -459 | -429 | -402 | ||||||
| Stockholders Equity | 195 | 109 | 45 | 22 | 15 | 50 | 79 | 113 | 73 | 97 | 47 | 48 | ||||||
| Liabilities And Stockholders Equity | 522 | 402 | 328 | 276 | 257 | 227 | 230 | 253 | 177 | 197 | 118 | 112 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 115 | 115 | 115 | 115 | 115 | 115 | 115 | 115 | 115 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 89 | 88 | 87 | 87 | 86 | 85 | 85 | 85 | 76 | 76 | 69 | 65 | ||||||
| Shares Outstanding | 89 | 88 | 87 | 87 | 86 | 85 | 85 | 85 | 76 | 76 | 69 | 65 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialLiquidia Corp (LQDA) — SEC Financial Statements & Analysis
Liquidia Corp (LQDA) is a pharmaceutical preparations company, incorporated in DE. Liquidia Corp trades on Nasdaq as: LQDA. Liquidia Corp (LQDA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, Liquidia Corp carries a market cap of $7.09B, a P/E ratio of 51.13x, a P/B ratio of 36.32x, a P/S ratio of 15.72x, an enterprise value of $6.80B, and an EV/EBITDA multiple of 39.95x. On profitability, it posts a gross margin of 95.87%, an operating margin of 37.39%, a net margin of 30.74%, a Return on Equity (ROE) of 131.82%, and a Return on Assets (ROA) of 35.57%. Per share, it reports EPS of $1.56, diluted EPS of $1.37, free cash flow per share of $1.70, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 2233.65% year-over-year, net income growth of -192.72% year-over-year, and EPS growth of -189.28% year-over-year. On the balance sheet, it maintains a current ratio of 2.31x, a quick ratio of 2.07x, working capital of $248.41M, a debt-to-equity ratio of 1.67x, a debt ratio of 0.63, an interest coverage ratio of 6.33x, free cash flow of $150.69M (TTM), and net debt of $-284.18M. Figures sourced from SEC EDGAR.
- Market Cap
- $7.09B
- P/E TTM
- 51.13x
- EPS TTM
- $1.56
- P/B TTM
- 36.32x
- ROE TTM
- 131.82%
- ROA TTM
- 35.57%
- Debt To Equity
- 1.67x
- Free Cash Flow TTM
- $150.69M
- Net Revenue TTM Growth 1Y
- 2233.65%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Liquidia Corp in?
Liquidia Corp (LQDA) operates in the Pharmaceutical Preparations industry.
What exchange does LQDA trade on?
Liquidia Corp (LQDA) trades on the Nasdaq.
Where is Liquidia Corp incorporated?
Liquidia Corp is incorporated in DE.
When was Liquidia Corp (LQDA)'s most recent SEC filing?
Liquidia Corp (LQDA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is LQDA's market cap?
Liquidia Corp (LQDA) has a market capitalization of $7.09B as of 2026-06-30.
What is LQDA's P/E ratio?
Liquidia Corp (LQDA)'s trailing twelve month P/E ratio is 51.13x as of 2026-06-30.
What is LQDA's EPS (earnings per share)?
Liquidia Corp (LQDA)'s trailing twelve month EPS is $1.56 as of 2026-06-30.
What is LQDA's ROE (return on equity)?
Liquidia Corp (LQDA)'s trailing twelve month Return on Equity (ROE) is 131.82% as of 2026-06-30.
What is LQDA's ROA (return on assets)?
Liquidia Corp (LQDA)'s trailing twelve month Return on Assets (ROA) is 35.57% as of 2026-06-30.
What is LQDA's EV/EBITDA?
Liquidia Corp (LQDA)'s trailing twelve month EV/EBITDA is 39.95x as of 2026-06-30.